A case of generalized morphea profunda following SARS-CoV-2 infection

JAAD Case Rep. 2022 May:23:20-23. doi: 10.1016/j.jdcr.2022.02.033. Epub 2022 Mar 12.

Authors

Michael R Stephens¹, Duncan F Moore², Jonathan Dau³, Soma Jobbagy⁴, Victor A Neel¹, Marcy B Bolster², Flavia Fedeles¹

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
² Division of Rheumatology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
³ UC Health Cherry Creek, Denver, Colorado.
⁴ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Keywords: IL, interleukin; SARS-CoV-2; fibrosing skin disorder; inflammatory cytokines; morphea; tocilizumab.

Publication types

Case Reports